ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 170 filers reported holding ARGENX SE in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,242,177 | +13.3% | 16,765 | -10.2% | 0.18% | +18.7% |
| Q2 2023 | $7,274,310 | -80.8% | 18,665 | -84.4% | 0.16% | -80.4% |
| Q1 2022 | $37,837,000 | -10.0% | 120,000 | 0.0% | 0.79% | +21.7% |
| Q4 2021 | $42,023,000 | +16.0% | 120,000 | 0.0% | 0.65% | +36.9% |
| Q3 2021 | $36,240,000 | -66.3% | 120,000 | -66.4% | 0.47% | -57.1% |
| Q2 2021 | $107,482,000 | +3.9% | 357,000 | -4.9% | 1.11% | +8.2% |
| Q1 2021 | $103,420,000 | -25.2% | 375,540 | -20.1% | 1.02% | -7.0% |
| Q4 2020 | $138,222,000 | +12.0% | 470,000 | 0.0% | 1.10% | +17.5% |
| Q3 2020 | $123,384,000 | +16.6% | 470,000 | 0.0% | 0.94% | -3.4% |
| Q2 2020 | $105,858,000 | +1507.1% | 470,000 | +840.0% | 0.97% | +987.6% |
| Q1 2020 | $6,587,000 | -17.9% | 50,000 | 0.0% | 0.09% | -11.0% |
| Q4 2019 | $8,026,000 | – | 50,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |